The New Hemp Energy Drink Will Be Offered to Consumers in 700 Additional Stores in Five Provinces
18 Juillet 2019 - 2:00PM
Tetra Natural Heath, a subsidiary of Tetra Bio-Pharma (TSX VENTURE:
TBP) (OTCQB: TBPMF), is pleased to announce that one of the largest
food and convenience store chains in North America has committed to
carry the Hemp Energy Drink in over 600 stores, bringing the total
number of new stores offering the product in the past two weeks to
approximately 700 stores located in five provinces of Canada
including: British-Columbia, Alberta, Saskatchewan, Manitoba and
Ontario. Visit www.hempenergydrink.ca for store locations.
The beverages will be offered to consumers as of
today in several stores with all stores in the five provinces
receiving their supply within the next two weeks. The distribution
commitment is for the three popular flavours of the Hemp Energy
Drink – Classic, Mango and Raspberry.
"We are very pleased with this agreement because
the demand for our Hemp Energy Drink has been extremely positive
since the product launch," said Tetra Natural Health CEO Richard
Giguère. "This new national rollout in five provinces will allow us
to better serve our ever-growing consumer base and will add to the
new stores that were announced in Quebec earlier this
week”.
Tetra Natural Heath is an emerging player in the
identification, development and marketing of hemp or
cannabinoids-based products authorized for sale by Health Canada.
The new Hemp Energy Drink (HED) contains more natural ingredients
than other energy drinks, and is the first energy drink made with
hemp available in the Canada.
"Securing a partnership with one of the largest
chains of food and convenience stores in North America validates
our HED’s quality and will improve our ability to quickly meet
consumer demand," Giguère added.
About Tetra Natural
Health:Tetra Natural Health Inc. is a subsidiary of Tetra
Bio-Pharma Inc. that focuses on identification, development and
marketing of hemp or cannabis-based natural health products, or
cannabinoids-based products authorized for sale by Health Canada.
For more information, visit: www.tetranaturalhealth.com
About Tetra Bio-Pharma:Tetra
Bio-Pharma (TSX-V: TBP) (OTCQB: TBPMF) a biopharmaceutical leader
in cannabinoid-based drug discovery and development with
a Health Canada approved and FDA reviewed
clinical program aimed at bringing novel prescription drugs and
treatments to patients and their healthcare providers. Tetra
Bio-Pharma has subsidiaries engaged in the development of an
advanced and growing pipeline of Bio Pharmaceuticals, Natural
Health and Veterinary Products containing cannabis and other
medicinal plant-based elements. With patients at the core of its
mission, Tetra Bio-Pharma is focused on providing
rigorous scientific validation and safety data required for
inclusion into the existing bio pharma industry by regulators,
physicians and insurance companies. For more information
visit: www.tetrabiopharma.com
More information at: www.tetrabiopharma.com
Source: Tetra Bio-Pharma
Neither the TSX Venture Exchange nor its Regulation Services
Provider (as that term is defined in the policies of the TSX
Venture Exchange) accepts responsibility for the adequacy or
accuracy of this release.
Forward-looking statementsSome
statements in this release may contain forward-looking information.
All statements, other than of historical fact, that address
activities, events or developments that the Company believes,
expects or anticipates will or may occur in the future (including,
without limitation, statements regarding potential acquisitions and
financings) are forward-looking statements. Forward-looking
statements are generally identifiable by use of the words "may",
"will", "should", "continue", "expect", "anticipate", "estimate",
"believe", "intend", "plan" or "project" or the negative of these
words or other variations on these words or comparable terminology.
Forward-looking statements are subject to a number of risks and
uncertainties, many of which are beyond the Company's ability to
control or predict, that may cause the actual results of the
Company to differ materially from those discussed in the
forward-looking statements. Factors that could cause actual results
or events to differ materially from current expectations include,
among other things, without limitation, the inability of the
Company to obtain sufficient financing to execute the Company's
business plan; competition; regulation and anticipated and
unanticipated costs and delays, the success of the Company's
research and development strategies, the applicability of the
discoveries made therein, the successful and timely completion and
uncertainties related to the regulatory process, the timing of
clinical trials, the timing and outcomes of regulatory or
intellectual property decisions and other risks disclosed in the
Company's public disclosure record on file with the relevant
securities regulatory authorities. Although the Company has
attempted to identify important factors that could cause actual
results or events to differ materially from those described in
forward-looking statements, there may be other factors that cause
results or events not to be as anticipated, estimated or intended.
Readers should not place undue reliance on forward-looking
statements. While no definitive documentation has yet been signed
by the parties and there is no certainty that such documentation
will be signed The forward-looking statements included in this news
release are made as of the date of this news release and the
Company does not undertake an obligation to publicly update such
forward-looking statements to reflect new information, subsequent
events or otherwise unless required by applicable securities
legislation.
More information
at: www.tetrabiopharma.com
For more information, please contact:Tetra Natural Health
Richard Giguère, CEOTel.: (438) 899-7575 ext.
210rgiguere@tetranaturalhealth.com
For investors information, please contact:
investors@tetrabiopharma.com (438) 504-5784
Media
Contacts - Tetra Natural Health Hemp Energy Drink |
Daniel Granger ACJ
CommunicationW. 514 840-7990M. 514 232
1556Daniel.granger@acjcommunication.com |
Charlotte BlancheACJ
CommunicationW. 514 840-1235, ext. 7772M. 514
914-0593c.blanche@acjcommunication.com |
A photo accompanying this announcement is available at
https://www.globenewswire.com/NewsRoom/AttachmentNg/fb09b4e4-ece0-4576-94da-0ec7d07a66bf
Tetra Bio Pharma (TSXV:TBP)
Graphique Historique de l'Action
De Déc 2024 à Jan 2025
Tetra Bio Pharma (TSXV:TBP)
Graphique Historique de l'Action
De Jan 2024 à Jan 2025